Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 3,178 shares at $7.80 ($25K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $25k BLUE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |